COvid-19 aNd TechNology - thE Impact on Clinical Trial Patients

NCT04852809 | Completed

• 1 other identifier: CFTSp197
• Study Type: observational
• Target: 138
• Locations: 1 country
• Sites: 1

Brief Summary

This is a 2 part qualitative study involving a questionnaire (part 1) and focus group discussions (part 2). The purpose of the study is to evaluate how patients' attitudes to technology in the oncology clinical trials setting since the start of the Coronavirus pandemic in 2020, and to assess how their use of technology has changed during this time. Part 1 of the study will be conducted via a self-report questionnaire to 100-140 cancer patients involved in clinical trials at The Christie NHS Foundation Trust over a 2 month period. Following this, three focus groups with a maximum of 8 participants in each group will take place to further assess patients' experiences with technology during the pandemic. Participants may take part in part 1 or part 2 only, or in both.

Conditions

Cancer

Outcome Measures

Primary Outcomes (1)

• To evaluate patients' attitudes to technology in the clinical trial setting since the coronavirus pandemic 2020.

  9 months

Secondary Outcomes (1)

• To assess changes in patients use of technology in oncology clinical trials prior to and since the coronavirus pandemic 2020.

  9 months

Other Outcomes (4)

• To determine how coronavirus pandemic has impacted the use of technology in the delivery of oncology trials for patients.

  9 months

• To assess the relationship between socioeconomic status and age and how it impacts the use of technology

  9 months

• To evaluate the challenges and opportunities of using technology in the future in the delivery of clinical trials technologies for future patient care.

  9 months

Study Arms (2)

Questionnaire

Observational

Other: No intervention

Focus Group

Observational

Other: No intervention

Interventions

No intervention OTHER

This is an observational study

Focus Group; Questionnaire

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Participants will all be clinical trial patients from The Christie NHS Foundation Trust who meet the eligibility criteria.

You may qualify if:

• Participants are eligible to be included in the study only if all of the following criteria apply:
• Patients have to be 18 years of age or older.
• Patients have to be currently enrolled on a phase I, II or III cancer related clinical trial within the Christie NHS Foundation Trust

You may not qualify if:

• Participants are excluded from the study if any of the following criteria apply:
• Unable to understand and converse in English for the focus group session.
• Patient not currently involved in a phase I, II or III clinical trial

Sponsors & Collaborators

• The Christie NHS Foundation Trust: lead

Study Sites (1)

The Christie NHS Foundation Trust

Manchester, Greater Manchester, M20 4BX, United Kingdom

Location

Related Links

• HRA website for results summary

MeSH Terms

Conditions

Neoplasms

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: April 16, 2021
• First Posted: April 21, 2021
• Study Start: May 18, 2021
• Primary Completion: March 10, 2022
• Study Completion: March 10, 2022
• Last Updated: April 13, 2023

Record last verified: 2023-04

Data Sharing

• IPD Sharing: Will not share

Locations

GB (1)